期刊
FEMS MICROBIOLOGY LETTERS
卷 328, 期 1, 页码 61-69出版社
OXFORD UNIV PRESS
DOI: 10.1111/j.1574-6968.2011.02476.x
关键词
Burkholderia cenocepacia; long-chain fatty acids; docosahexaenoic acid; antibacterial agent
类别
资金
- FEDER
- Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/QUI/67925/2006, PTDC/BIA-MIC/71453/2006, PTDC/EBB-BIO/100326/2008]
- Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/71453/2006, PTDC/QUI/67925/2006, PTDC/EBB-BIO/100326/2008] Funding Source: FCT
Burkholderia cepacia complex (Bcc) bacteria are opportunistic pathogens that cause multiresistant pulmonary infections in patients with cystic fibrosis (CF). In this study, we evaluated the in vitro antimicrobial efficacy of eight unsaturated fatty acids against Burkholderia cenocepacia K56-2, a CF epidemic strain. Docosahexaenoic acid (DHA) was the most active compound. Its action can be either bacteriostatic or bactericidal, depending upon the concentration used. The effect of DHA was also evaluated on two others B.cenocepacia clinical isolates and compared with one representative member of all the 17 Bcc species. To test whether DHA could have a therapeutic potential, we assessed its efficacy using a Galleria mellonella caterpillar model of B.cenocepacia infection. We observed that the treatment of infected larvae with a single dose of DHA (50 mM) caused an increase in the survival rate as well as a reduced bacterial load. Moreover, DHA administration markedly increases the expression profile of the gene encoding the antimicrobial peptide gallerimycin. Our results demonstrate that DHA has in vitro and in vivo antibacterial activity against Bcc microorganisms. These findings provide evidence that DHA may be a useful nutraceutical for the treatment of CF patients with lung infections caused by antibiotic multiresistant Bcc microorganisms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据